Literature DB >> 33763767

Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.

Ankita Banerjee1, Lilesh Kumar Pradhan1, Santosh Chauhan2, Pradyumna Kumar Sahoo1, Kautilya Kumar Jena2, Nishant Ranjan Chauhan2, Saroj Kumar Das3.   

Abstract

Increasing incidences of neurological disorders, such as Parkinson's disease (PD), multiple sclerosis (MS), Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) are being reported, but an insight into their pathology remains elusive. Findings have suggested that gut microbiota play a major role in regulating brain functions through the gut-brain axis. A unique bidirectional communication between gut microbiota and maintenance of brain health could play a pivotal role in regulating incidences of neurodegenerative diseases. Contrarily, the present life style with changing food habits and disturbed circadian rhythm may contribute to gut homeostatic imbalance and dysbiosis leading to progression of several neurological disorders. Therefore, dysbiosis, as a primary factor behind intestinal disorders, may also augment inflammation, intestinal and blood-brain barrier permeability through microbiota-gut-brain axis. This review primarily focuses on the gut-brain axis functions, specific gut microbial population, metabolites produced by gut microbiota, their role in regulating various metabolic processes and role of gut microbiota towards development of neurodegenerative diseases. However, several studies have reported a decrease in abundance of a specific gut microbial population and a corresponding increase in other microbial family, with few findings revealing some contradictions. Reports also showed that colonization of gut microbiota isolated from patients suffering from neurodegenerative disease leads to the development of enhance pathological outcomes in animal models. Hence, a systematic understanding of the dominant role of specific gut microbiome towards development of different neurodegenerative diseases could possibly provide novel insight into the use of probiotics and microbial transplantation as a substitute approach for treating/preventing such health maladies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Dysbiosis; Gut microbiota; Gut–brain axis; Microbial transplantation; Neurodegenerative diseases; Probiotics

Mesh:

Year:  2021        PMID: 33763767     DOI: 10.1007/s00203-021-02276-9

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  171 in total

Review 1.  Host-bacterial mutualism in the human intestine.

Authors:  Fredrik Bäckhed; Ruth E Ley; Justin L Sonnenburg; Daniel A Peterson; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 2.  Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals.

Authors:  Mohd Iqbal Bhat; Rajeev Kapila
Journal:  Nutr Rev       Date:  2017-05-01       Impact factor: 7.110

Review 3.  Microbiome-Modulated Metabolites at the Interface of Host Immunity.

Authors:  Eran Blacher; Maayan Levy; Evgeny Tatirovsky; Eran Elinav
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

4.  γ-Aminobutyric acid production by culturable bacteria from the human intestine.

Authors:  E Barrett; R P Ross; P W O'Toole; G F Fitzgerald; C Stanton
Journal:  J Appl Microbiol       Date:  2012-06-15       Impact factor: 3.772

Review 5.  Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.

Authors:  Siân C Barber; Richard J Mead; Pamela J Shaw
Journal:  Biochim Biophys Acta       Date:  2006-04-04

6.  Potential roles of gut microbiome and metabolites in modulating ALS in mice.

Authors:  Eran Blacher; Stavros Bashiardes; Hagit Shapiro; Daphna Rothschild; Uria Mor; Mally Dori-Bachash; Christian Kleimeyer; Claudia Moresi; Yotam Harnik; Maya Zur; Michal Zabari; Rotem Ben-Zeev Brik; Denise Kviatcovsky; Niv Zmora; Yotam Cohen; Noam Bar; Izhak Levi; Nira Amar; Tevie Mehlman; Alexander Brandis; Inbal Biton; Yael Kuperman; Michael Tsoory; Leenor Alfahel; Alon Harmelin; Michal Schwartz; Adrian Israelson; Liisa Arike; Malin E V Johansson; Gunnar C Hansson; Marc Gotkine; Eran Segal; Eran Elinav
Journal:  Nature       Date:  2019-07-22       Impact factor: 49.962

7.  The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation.

Authors:  Tarun Bansal; Robert C Alaniz; Thomas K Wood; Arul Jayaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

Review 8.  The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  Neuroscience       Date:  2020-02-27       Impact factor: 3.590

Review 9.  Interactions between the microbiota and pathogenic bacteria in the gut.

Authors:  Andreas J Bäumler; Vanessa Sperandio
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

10.  C-reactive protein and risk of cognitive decline: The REGARDS study.

Authors:  Miguel Arce Rentería; Sarah R Gillett; Leslie A McClure; Virginia G Wadley; Stephen P Glasser; Virginia J Howard; Brett M Kissela; Frederick W Unverzagt; Nancy S Jenny; Jennifer J Manly; Mary Cushman
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

View more
  3 in total

1.  Gastrointestinal Tract Microbiome-Derived Pro-inflammatory Neurotoxins in Alzheimer's Disease.

Authors:  Yuhai Zhao; Vivian Jaber; Walter J Lukiw
Journal:  J Aging Sci       Date:  2021-05-27

Review 2.  The Potential Role of m6A in the Regulation of TBI-Induced BGA Dysfunction.

Authors:  Peizan Huang; Min Liu; Jing Zhang; Xiang Zhong; Chunlong Zhong
Journal:  Antioxidants (Basel)       Date:  2022-08-04

3.  Exercise Interventions Improved Sleep Quality through Regulating Intestinal Microbiota Composition.

Authors:  Liangwu Qiu; Fuhong Gong; Jiang Wu; Dingyun You; Yinzhou Zhao; Lianwu Xu; Xue Cao; Fukai Bao
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.